EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $386,000 | -55.0% | 9,085 | -40.1% | 0.01% | -68.2% |
| Q3 2019 | $858,000 | -0.7% | 15,173 | -2.2% | 0.02% | +29.4% |
| Q2 2019 | $864,000 | +14.4% | 15,512 | +3.7% | 0.02% | -10.5% |
| Q1 2019 | $755,000 | +167.7% | 14,952 | +267.6% | 0.02% | +280.0% |
| Q3 2018 | $282,000 | +12.8% | 4,068 | +23.0% | 0.01% | +25.0% |
| Q2 2018 | $250,000 | +4.6% | 3,307 | -27.2% | 0.00% | 0.0% |
| Q1 2018 | $239,000 | +6.2% | 4,542 | +7.9% | 0.00% | 0.0% |
| Q4 2017 | $225,000 | -65.4% | 4,210 | -49.0% | 0.00% | -60.0% |
| Q2 2017 | $651,000 | +25.9% | 8,258 | +32.6% | 0.01% | +42.9% |
| Q1 2017 | $517,000 | – | 6,229 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |